TWiV 1353: Phage bet-hedging and EBV antibodies

Aug 30, 2026 · 1h 52m

Coming soon to iPhone. Already have it? “Listen in Starcast” takes you straight there.

On this episode

BBBrianne BarkerHost
JRJolene RamseyHost
RCRich ConditHost
Vincent RacanielloHost

About this episode

TWiV explores how bacteriophages enable bet-hedge against bacterial immune defenses, and how transgenic mice engineered to produce human antibodies yielded potent anti-EBV candidates targeting gp350 and gp42, a promising step toward Epstein-Barr therapeutics. Hosts: Vincent Racaniello , Rich Condit , Brianne Barker, and Jolene Ramsey Subscribe (free): Apple Podcasts , RSS , email Become a patron of TWiV! Links for this episode Support science education at MicrobeTV Dolly Parton , and advocate for science (Nature) Phage bet-hedging (Nat Micro) EBV monoclonal antibodies (Cell Rep Med) Letters read on TWiV 1353 Timestamps by Jolene Ramsey. Thanks! Picks of the Week Brianne – Did life on Earth…